⭐️ @AKBhatiaMD presenting this @wustlcardfellow research project. Mentored by @medtmaddox & @HealthInnovLab
@ACCinTouch @akates1 @husainim @prathakker @nfrogge @kejoynt @DoctorPhillEP @CMcNeelyMD @AdamMay64908870
The burden of HF is real. Both clinical & economic.
Are we not doing the conventional stuff effective enough?
Fresh from ACC 2021.
CONNECT-HF with no change in CV outcomes or quality of life outcomes.
What is our goal for our outpatient HF patients?
The two tenets to keep in mind
💊OMT
⚡️vigilance for clinical decompensation).
What are we missing when we are not prescribing target doses?
Remote patient monitoring can fill this gap and start to address some of these barriers
A majority of traditional remote monitoring systems have not demonstrated any efficacy.
How do we bridge the efficacy gap?
The Myia trial came from a research partnership from @HealthInnovLab, @ACCinTouch, & @BarnesJewish
Myia was a collaborative single-arm single-center trail
Interim data from the Myia trial.
Patients like the platform
No change in symptoms
2.5 medication changes over 6 months
More interim data
Let's take a step back. What did we learn?
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.